Test Price
1,200 AED✅ Home Collection Available
Immunohistochemistry (Any 5 Markers) Panel – Precise FFPE Tissue Subtyping in Dubai
Executive Summary & Core Metrics
- Target: Archival or recent FFPE tumour tissue for comprehensive protein expression profiling.
- Methodology: Automated IHC (Ventana/Roche) with dual-antibody validation for maximum specificity and reproducibility.
- Turnaround Time: 5–7 working days from receipt of an adequate specimen.
- Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval. Note: This is an archival tissue specimen; mobile home phlebotomy is disabled. Hospital extraction only for new biopsies.
- Post-Test Consultation: Telephonic guidance with Mr. Prabhakar Reddy Kalathoor (Specialist Diagnostic Radiology) to correlate IHC results with clinical imaging and history.
Test Overview & Methodology
This targeted 5-marker immunohistochemistry panel uses monoclonal antibodies to detect specific protein antigens on cancer cells within formalin-fixed, paraffin-embedded (FFPE) tissue. By precisely identifying protein expression patterns, the panel enables oncologists to subtype malignancies, select targeted therapies, and refine prognostic accuracy. The process utilises an automated staining platform with rigorous dual-antibody validation, ensuring over 99% diagnostic sensitivity and specificity for the requested markers.
| Feature | DNA Labs UAE 5-Marker IHC Panel | Conventional Alternative |
|---|---|---|
| Platform | Fully automated (Ventana/Roche) with digital image analysis | Manual staining with subjective scoring |
| Antibody Validation | Dual-antibody validated clones per target | Single antibody set, lower concordance |
| Turnaround Time | 5–7 working days | 7–10 working days |
| Regulatory Alignment | DHA-MOHAP nomenclature, PDPL 2021 compliant | Often lacks explicit DHA protocol alignment |
Physician Insight & Safety Protocols
“An IHC panel is a powerful diagnostic lens, but it must be correlated with full-field morphology and the patient’s clinical narrative. At DNA Labs UAE, we integrate automated image analysis with expert correlation to ensure the reported markers truly represent the tumour’s driving biology. The selection of the right five markers is a critical step that directly influences therapeutic decisions.”
— Mr. Prabhakar Reddy Kalathoor | Specialist Diagnostic Radiology | DHA Registration ID: 61713011
⚠️ Advisory: Specimen Integrity & Medication
Optimal IHC results depend on proper tissue fixation and processing. Ensure the specimen is placed in 10% neutral buffered formalin immediately upon collection. Do not discontinue anticoagulants, immunosuppressants, or any prescribed medication without explicit instruction from your treating physician.
🚨 Exclusion Criteria & Emergency Red Flags
- Exclusion: Insufficient tissue (< 1 mm core), extensively necrotic or cauterised specimens, haemorrhagic fluid samples, or use of non-formalin fixatives (alcohol, Bouin’s).
- Emergency Signs: Sudden severe pain at biopsy site, uncontrolled bleeding, high fever (>38.5°C), or rapid swelling after biopsy — proceed to the nearest ER immediately.
Patient FAQ & Clinical Guidance
1. How does this 5-marker IHC panel influence my cancer treatment plan?
This panel identifies specific protein expression patterns (e.g., ER, PR, HER2, Ki-67, CK5/6) that classify your tumour into molecular subtypes. This classification directly guides the selection of targeted therapies, hormonal treatments, and chemotherapy regimens, moving beyond broad morphology-based diagnosis to personalised oncology.
2. What type of tissue sample is required, and how do I arrange the logistics?
We require a formalin-fixed paraffin-embedded (FFPE) block or unstained slides cut at 4-µm thickness. Our team arranges a Secure Medical Courier Solid Tissue Specimen Retrieval from your hospital or clinic. Since this is an archival specimen evaluation, mobile home phlebotomy is disabled. Please ensure the original histopathology report and clinical summary accompany the tissue.
3. Does my UAE health insurance cover this IHC panel?
Most comprehensive UAE health insurance plans cover IHC panels when deemed medically necessary by an oncologist. We offer direct billing verification via WhatsApp (+971 54 548 8731) before the test is performed, and we provide flexible self-pay options for uninsured patients, fully compliant with UAE PDPL data privacy standards.
UAE Regulatory & Data Privacy Adherence
Your health data is protected under the UAE’s strictest legal frameworks.
- Data Privacy & Security: Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health ICT Compliance: Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability & Consent: Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- All results are transmitted through encrypted channels, and identifiable patient data is anonymised for clinical reporting and diagnostic accuracy.
Clinical & Logistical Metadata
| Test Name | Immunohistochemistry (Any 5 Markers) Panel |
| Price (AED) | 1,200 AED |
| Turnaround Time | 5–7 Working Days |
| Sample Type / Matrix | Archival FFPE Tissue Block / Unstained Slides |
| Methodology Used | Automated Immunohistochemistry (Ventana/Roche) with Dual‑Antibody Validation |
| ICD-10-CM Code | C80.1, Z85.9 |
| LOINC Code | 77599-8 |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians